Selective Bibliography of Dr. Allan Weissman
Laboratory of Protein Dynamics and Signaling, NCI

"The Ubiquitin-Proteasome System: Insights from Degrading Experienes"
Wednesday, October 14, 2009

1. Das R, Mariano J, Tsai YC, Kalathur RC, Kostova Z, Li J, Tarasov SG, McFeeters RL, Altieri AS, Ji XH, Byrd RA, Weissman AM
Allosteric Activation of E2-RING Finger-Mediated Ubiquitylation by a Structurally Defined Specific E2-Binding Region of gp78
MOLECULAR CELL 34 (6):674-685 2009

2. Kostova Z, Mariano J, Scholz S, Koenig C, Weissman AM
A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation
JOURNAL OF CELL SCIENCE 122 (9):1374-1381 2009

3. Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM, Weissman AM, Ambs S
Differences in the tumor microenvironment between African-American and European-American breast cancer patients
PLOS ONE 4 (2):e4531 2009

4. Clement JA, Kitagaki J, Yang Y, Saucedo CJ, O'Keefe BR, Weissman AM, Mckee TC, McMahon JB
Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
BIOORGANIC & MEDICINAL CHEMISTRY 16 (23):10022-10028 2008

5. Cohen MMJ, Leboucher GP, Livnat-Levanon N, Glickman MH, Weissman AM
Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion
MOLECULAR BIOLOGY OF THE CELL 19 (6):2457-2464 2008

6. Ding W, Li CX, Hu TH, Graves-Deal R, Fotia AB, Weissman AM, Coffey RJ
EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 105 (36):13433-13438 2008

7. Kitagaki J, Agama KK, Pommier Y, Yang YL, Weissman AM
Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
MOLECULAR CANCER THERAPEUTICS 7 (8):2445-2454 2008

8. Shenoy SK, Xiao KH, Venkataramanan V, Snyder PM, Freedman NJ, Weissman AM
Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta(2)-adrenergic receptor
JOURNAL OF BIOLOGICAL CHEMISTRY 283 (32):22166-22176 2008

9. Weissman AM
How much REST is enough?
CANCER CELL 13 (5):381-383 2008

10. Sasiela CA, Stewart DH, Kitagaki J, Safiran YJ, Yang YL, Weissman AM, Oberoi P, Davydov IV, Goncharova E, Beutler JA, McMahon JB, O'Keefe BR
Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen
JOURNAL OF BIOMOLECULAR SCREENING 13 (3):229-237 2008

Created 10/7/09